Media Outlets Examine Various Aspects Of Novel Coronavirus Vaccine R&D, Access, Funding

Bloomberg: U.K. Orders 90 Million Vaccine Doses from Pfizer, Valneva (Mulier, 7/20).

Bloomberg: Most of the World May Face Covid Without a Vaccine (Paton, 7/18).

Chicago Tribune: How will the first COVID-19 vaccine affect women? ‘This leaves a big question mark’ (Bowen, 7/19).

CNN: Why North Korea says it’s joining the coronavirus vaccine race, even though it has no cases (Berlinger, 7/20).

Financial Times: Britain signs up for 90m doses of German and French vaccines (Miller/Cookson, 7/20).

Financial Times: Pre-fab vaccine facilities aim to help fill production gap (Miller, 7/19).

Financial Times: World must pick sides in vaccines battle, says Russian wealth fund chief (Foy/Seddon, 7/17).

Homeland Preparedness News: COVAX Facility builds coalition of more than 160 countries interested in equitable COVID-19 vaccines (Galford, 7/17).

New York Times: Mistrust of a Coronavirus Vaccine Could Imperil Widespread Immunity (Hoffman, 7/18).

POLITICO: Europe’s challenge of a lifetime: Manufacturing enough coronavirus vaccines (Furlong, 7/18).

POLITICO Magazine: An Indian drug mogul says Americans will pay too much for the Covid vaccine — and wants to change that (Wheaton, 7/19).

STAT: 6 burning questions Congress could push Covid-19 vaccine makers to answer (Garde/Branswell, 7/20).

The Telegraph: Russian elite received experimental Covid-19 vaccine in April, reports say (Vasilyeva, 7/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.